Clenoliximab Chimeric Recombinant Rabbit Monoclonal Antibody (CE9.1 (Clenoliximab))

MA547969

Specificity: The antibody binds to human CD4 with a Kd of 1.0 nM and an ED50 of 0.2 μg/mL. Clenoliximab is a chimeric monoclonal antibody fromMacaca irusagainst CD4 which acts as an immunomodulator. It has investigated for the treatment of rheumatoid art

Certifications

CAT NUM

PRODUCT NAME

Pack Size

PRICE

QUANTITY

CAT NUM: MA547969

Clenoliximab Chimeric Recombinant Rabbit Monoclonal Antibody (CE9.1 (Clenoliximab))

Pack Size: 200 μg

PRICE:

Antigen

Clenoliximab Chimeric

Applications

Surface Plasmon Resonance

Classification

Recombinant Monoclonal

Clone

CE9.1 (Clenoliximab)

Concentration

1 mg/mL

Conjugate

Unconjugated

Form

Liquid

Formulation

PBS with 0.02% ProClin 300

Gene Alias

4PE; IDEC-151

Host Species

Rabbit

Immunogen

Domain 1 of human CD4.

Isotype

IgG λ

Primary or Secondary

Primary

Product Type

Antibody

Purification Method

Protein A

Regulatory Status

RUO

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Target Species

Human

Brand

Invitrogen

Pack Size

200 μg

Storage Temp

Freezer (-5 to -30 C)

Clenoliximab Chimeric Recombinant Rabbit Monoclonal Antibody (CE9.1 (Clenoliximab))

ORDER TABLE

SPECS & PROPERTIES

Description & Product Features